Literature DB >> 15692545

Has survival improved for nasopharyngeal carcinoma in the United States?

Jivianne T Lee1, Clifford Y Ko.   

Abstract

OBJECTIVE: To analyze the epidemiologic patterns and survival rates for patients with nasopharyngeal carcinoma over the last three decades.
METHODS: The National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) program tumor registries were used to identify patients with nasopharyngeal carcinoma in the United States from 1973 to 1999. Incidence and survival rates for each decade were then determined according to age, gender, race, histological type, and stage using the SEER statistical program.
RESULTS: From 1973 to 1999, 4680 cases of patients with nasopharyngeal carcinoma in the United States were sampled by the NCI /SEER database. Overall incidence rates for each decade essentially remained unchanged over time (0.7/100,000). Asians exhibited the highest incidence rates (3.0-4.2), followed by blacks (0.7-1.1) and then whites (0.4-0.7). In contrast, survival rates have gradually improved over time for all stages and histological types (35.7% 5-year survival in the 1970s vs. 44.1% in the 1980, and 51% in the 1990s). With respect to race, Asians demonstrated the best 5-year survival rate (62.9%) followed by whites (42.6%) and then blacks (36.2%). However, this may be due to histology, because Asians were also found to have a greater proportion of World Health Organization (WHO) type III cases (27.6%) in comparison to the other 2 groups (22.4% for blacks and 15% for whites).
CONCLUSIONS: Although the incidence rates of nasopharyngeal carcinoma have remained essentially unchanged in the United States in the last 3 decades, survival rates for each stage and histological subtype have exhibited considerable improvement over time. The higher survival rates in Asians may be partially attributed to the more favorable histology (type III) often seen in this group. EBM RATING: B-3.

Entities:  

Mesh:

Year:  2005        PMID: 15692545     DOI: 10.1016/j.otohns.2004.09.018

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  Nasopharyngeal Carcinoma Diagnostic Challenge in a Nonendemic Setting: Our Experience with 101 Patients.

Authors:  Kevin H Wang; Stephanie A Austin; Sonia H Chen; David C Sonne; Deepak Gurushanthaiah
Journal:  Perm J       Date:  2017

2.  The incidence of Epstein-Barr virus in nasopharyngeal carcinoma of Jordanian patients.

Authors:  Ismail Matalka; Mohammad Al Hamad; Maysa Al-Hussaini; Firas Q Alzoubi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-16       Impact factor: 2.503

3.  Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997.

Authors:  Juhua Luo; Kee Seng Chia; Sin Eng Chia; Marie Reilly; Chuen Seng Tan; Weimin Ye
Journal:  Eur J Epidemiol       Date:  2007-06-27       Impact factor: 8.082

4.  Racial differences in nasopharyngeal carcinoma in the United States.

Authors:  Yu Wang; Yawei Zhang; Shuangge Ma
Journal:  Cancer Epidemiol       Date:  2013-09-12       Impact factor: 2.984

Review 5.  The prevalence and prevention of nasopharyngeal carcinoma in China.

Authors:  Su-Mei Cao; Malcolm J Simons; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2011-02

6.  Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.

Authors:  Anna Merlotti; Daniela Alterio; Riccardo Vigna-Taglianti; Alessandro Muraglia; Luciana Lastrucci; Roberto Manzo; Giuseppina Gambaro; Orietta Caspiani; Francesco Miccichè; Francesco Deodato; Stefano Pergolizzi; Pierfrancesco Franco; Renzo Corvò; Elvio G Russi; Giuseppe Sanguineti
Journal:  Radiat Oncol       Date:  2014-12-29       Impact factor: 3.481

7.  Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.

Authors:  Jian Sun; Zhongying Huang; Zheyu Hu; Rui Sun
Journal:  J Transl Med       Date:  2017-05-30       Impact factor: 5.531

8.  Patterns and Prognostic Value of Lymph Node Metastasis on Distant Metastasis and Survival in Nasopharyngeal Carcinoma: A Surveillance, Epidemiology, and End Results Study, 2006-2015.

Authors:  Yali Xu; Taoyuan Huang; Liqin Fan; Wei Jin; Xiaoming Chen; Jinhai Chen
Journal:  J Oncol       Date:  2019-11-29       Impact factor: 4.375

Review 9.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.